Cardiac PET

Cardiac positron emission tomography (PET) is a nuclear imaging modality that can show heart cell metabolism that reveals areas of ischemia or infarct where this low or no blood flow due to coronary artery disease and myocardial infarction. PET can help determine in if areas of the heart effected by a heart attack can be reversed through revascularization. PET can also offer additional information on the patient's condition with myocardial flow reserve (MFR) information. Cardiac PET uses a rubidium (Rb-82) radiotracer injection, which only has a half life of 75 seconds, which greatly speeds scan times compared to traditional cardiac SPECT imaging.

SPECT still has an important role to play in nuclear cardiology
"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.
New imaging protocols proposed to curb rise of cardiovascular infections
Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.
ASNC president pushes to modernize nuclear cardiology, expand the specialty's reach
ASNC President Lawrence Phillips, MD, wants to see nuclear cardiologists modernize their labs and embrace new strategies for the evaluation of amyloidosis, sarcoidosis and inflammation.
DOJ targets former imaging executive with new complaint over alleged kickback scheme
Back in October, a mobile cardiac imaging provider and its CEO agreed to pay $85 million to settle allegations they had participated in a kickback scheme. This latest DOJ complaint focuses on a former executive not named in that initial settlement.
Cardiologists at heart of alleged kickback scheme—imaging provider, CEO to pay $85M to settle
The allegations revolve around payments referring cardiologists received to supervise PET scans from March 2014 to May 2023.

Video interview with Tim Bateman, MD, co-director, cardiovascular radiologic imaging program, Saint Luke's Mid America Heart Institute and an American Society of Nuclear Cardiology (ASNC) past-president, explaining the role of SPECT into the future as PET becomes more popular. A new look at PET vs SPECT.

SPECT still has an important role to play in nuclear cardiology

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

March 26, 2024

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

March 12, 2024

Video interview with ASNC President Lawrence Phillips, MD, NYU, who is encouraging the modernization of nuclear cardiology labs and expansion into new diagnostic areas.

ASNC president pushes to modernize nuclear cardiology, expand the specialty's reach

ASNC President Lawrence Phillips, MD, wants to see nuclear cardiologists modernize their labs and embrace new strategies for the evaluation of amyloidosis, sarcoidosis and inflammation.

February 7, 2024

DOJ targets former imaging executive with new complaint over alleged kickback scheme

Back in October, a mobile cardiac imaging provider and its CEO agreed to pay $85 million to settle allegations they had participated in a kickback scheme. This latest DOJ complaint focuses on a former executive not named in that initial settlement.

February 6, 2024

Cardiologists at heart of alleged kickback scheme—imaging provider, CEO to pay $85M to settle

The allegations revolve around payments referring cardiologists received to supervise PET scans from March 2014 to May 2023.

October 11, 2023

Timothy Bateman, MD, co-director, cardiovascular radiologic imaging program, Saint Luke's Mid America Heart Institute, professor of medicine at the University of Missouri-Kansas City School of Medicine, and an ASNC past-president, is one of the authors on the AURORA study. He spoke with Cardiovascular Business about the study and what it is like to work with flurpiridaz.

Flurpiridaz will have a major impact on cardiac PET and nuclear imaging

The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview.

October 10, 2023

doctor in handcuffs after being arrested

Cardiologist to pay $6.5M after trading kickbacks for imaging referrals in complex fraud scheme

In addition to the hefty fine, the New York physician has agreed to relinquish ownership of his cardiology practice after exchanging kickbacks for PET and SPECT referrals for more than a decade.

September 20, 2023

To hear about key trends in cardiac imaging, Cardiovascular Business spoke with two experts in cardiac imaging at American College of Cardiology (ACC) 2023 meeting, Marcelo DiCarli, MD, chief, division of nuclear medicine and molecular imaging, executive director for the cardiovascular imaging program, Brigham and Women's Hospital, and Rob Beanlands, MD, is director of the National Cardiac PET Centre at the University of Ottawa Heart Institute, Canada.

What's new in cardiac imaging? 2 experts discuss the latest trends

Marcelo DiCarli, MD, and Rob Beanlands, MD, shared their thoughts on the current state of cardiac imaging at ACC.23.

May 9, 2023